Jiangsu Vcare PharmaTech Co., Ltd., established in 2010, is a dynamic player in the Biopharma and Biotechnology sectors. Operating under the slogan, "Advancing pharmaceutical innovation through ground-breaking R&D, seamless generic drug technology transfer, and comprehensive production and sales solutions," the company focuses on the R&D of innovative drugs, the transfer of generic drug technology, and the production and sales of pharmaceuticals.
Recently, Jiangsu Vcare PharmaTech secured a CNY450.00M Series C investment on 02 January 2024, underscoring investor confidence in its growth prospects and strategic vision. Key investors include Dyee Capital, Nanjing Innovation Capital Group, China Life Private Equity Investment, Huadian Investment, and Hongyao Science and Technology.
The company's commitment to pharmaceutical innovation, paired with robust financial backing, positions it well for continued expansion and market impact in the rapidly evolving biopharma landscape.
